Upcoming Medical Conferences in TaiwanSearch Criteria : Taiwan
Feb 06 - 09, 2020 | Taipei, Taipei
The 9th World Congress of Facial Plastic Surgery is organized by the Taiwan Academy of Facial Plastic and Reconstructive Surgery (TAFPRS). The symposium will be held from Feb 06 - 09, 2020 at Taipei International Convention Center (TICC), Taipei, Taiwan. Preliminary Topics: • Rhinoplasty • Facelift • Otoplasty • Hair restoration • Advances in FPRS science • Blepharoplasty • Trauma in FPRS • Minimal invasive procedures • Functional reconstruction in FPRS • Facial contouring surgery • Others Additional details will be posted as soon as information is available.
15th Annual Scientific Meeting of Asia Pacific Society of Cardiovascular and Interventional Radiology (APSCVIR)
Mar 06 - 09, 2020 | Taipei, Taipei
15th Annual Scientific Meeting of Asia Pacific Society of Cardiovascular and Interventional Radiology (APSCVIR) is organized by Asia Pacific Society of Cardiovascular and Interventional Radiology (APSCVIR) and will be held from Mar 06 - 09, 2020 at Grand Hotel Taipei, Taipei, Taiwan. Additional details will be posted as soon as information is available.
Mar 07 - 08, 2020 | USD $499 | Taipei, Taipei
A4M - Taiwan Symposium Advanced IV Therapies is organized by American Academy of Anti-Aging Medicine (A4M) and will be held from Mar 07 - 08, 2020 at Regent Taipei, Taipei, Taiwan. Description: Designed to provide a firm foundational understanding of IV, Chelation, Stem cells, Nutritional therapies, detoxication while expanding upon various advanced IV protocols, this event is geared towards active clinicians seeking to effectively implement intravenous nutritional therapies into practice. Led by a team of seasoned experts, lectures will examine the use of vitamins, minerals, amino acids, and other unique parenteral compounds. Attendees will review various aspects of integrating IV therapy into practice, learn implementation strategies, and uncover the potential applications of the therapy in cancer. In analyzing a broad range of pertinent research and protocols, practitioners will leave with a solid understanding of how to best administer and integrate IV therapies into practice. Additional details will be posted as soon as information is available.
Apr 14 - 16, 2020 | Taipei, Taipei
8th Annual Biologics World Taiwan 2020 is organized by IMAPAC Pte Ltd and will be held from Apr 14 - 16, 2020 at Grand Victoria Hotel Taipei, Taipei, Taiwan. Description: Biologics World Taiwan provides the FIRST and ONLY platform for senior decision-makers who will influence the future of Taiwan’s biologics industry. Taiwanese and international biopharmas, biotechs, CMOs, CROs, and solution providers will convene to discuss strategic issues, leverage partnerships, share best practices, and capitalize on the potential of Taiwan’s growing biologics industry. Two biotechnology clusters have already been built in Taiwan, with the Southern Taiwan Science Park hosting nearly 20 biopharmaceutical companies, and the Hsinchu Biomedical Science Park expected to accommodate 30 biopharmaceutical manufacturers. The government also plans to create an integrated incubation center, to be developed in a third park and called the National Biotechnology Development Park, which will also contain animal testing, R&D service, and legal information centers. Additional details will be posted as soon as they are available.
Apr 14 - 16, 2020 | TWD NT$38500 | Taoyuan district, Taoyuan
2nd Instructional Course for Facial Paralysis Reconstruction (FPR) is organized by Chang Gung Memorial Hospital, Linkou Division of Plastic & Reconstructive Surgery and will be held from Apr 14 - 16, 2020 at Linkou Chang Gung Memorial Hospital, Taoyuan district, Taoyuan, Taiwan. Additional details will be posted as soon as information is available.
Apr 19 - 23, 2020 | Tainan, Tainan
Pacific Association of Pediatric Surgeons (PAPS) Annual conference is organized by Pacific Association of Pediatric Surgeons (PAPS) and will be held from Apr 19 - 23, 2020 at Tainan, Taiwan. Additional details will be posted as soon as they are available.
May 09 - 14, 2020 | Taipei, Taipei
59th Annual Conference of The Particle Therapy Co-Operative Group is organized by Particle Therapy Co-Operative Group (PTCOG) and will be held from May 09 - 14, 2020 at Nangang Exhibition Center, Taipei, Taiwan. Additional details will be posted as soon as they are available.
May 16 - 17, 2020 | Taipei, Taipei
50th Annual Convention & Scientific Session of the Taiwan Society of Cardiology (TSOC) is organized by Taiwan Society of Cardiology (TSOC) and will be held from May 16 - 17, 2020 at Taipei, Taiwan. Additional details will be posted as soon as information is available.
May 17 - 21, 2020 | USD $1145 | Taipei, Taipei
Inflammation, Microbiota and Cancer (E3) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from May 17 - 21, 2020 at Humanities/Social Sciences Building of Academia Sinica, Taipei, Taiwan. Description: The concept of inflammation being linked to a tumor promoting and in some case initiating microenvironment has evolved to include a complex network of interactions between innate resistance and acquired immunity; tumor, innate and immune cell metabolism; and the microbiota local and systemic effects on tumor predisposition, promotion, response to chemo, radio, and immune therapy as well as therapy toxicity and cancer co-morbidities. The metabolic tumor environment affects innate and immune cells metabolism and activity thus modulating the tumor progression and the response to therapy, particularly immunotherapy but also chemo and radiotherapy. Innate signaling also affects the tumor microenvironment and a complex cross-talk involving innate receptors, trained immunity, and class I MHC regulates both inflammation and anti-tumor immunity. Also, rapid progress in experimental animals and more recently in cancer patients is unraveling a complex interaction between the microbiota at epithelial surfaces or within the primary tumor and its metastases with response to therapy, raising the hope to be able to predict patient response to different types of therapy and to target the microbiota for improving therapy response, decreasing toxicity and preventing co-morbidity. These new scientific areas will be covered in this meeting that will bring together aspects of cancer biology and immunity often discussed only at separate specialized meetings. The presence of both basic and clinical investigators will expose the participants to these new concepts and will provide an opportunity to discuss and explore the clinical translation of this rapidly emerging new understanding of cancer immunobiology. Additional details will be posted as soon as they are available.